Skip to main content
VCbacked
Log inGet Started

Isosceles Pharmaceuticals

Wilmington, United States

Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.

$5.0M raised
Oct 2022
Equity Crowdfunding
Biotechnology

Top Investors

Equifund

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Isosceles Pharmaceuticals

How much funding has Isosceles Pharmaceuticals raised?
Isosceles Pharmaceuticals has raised $5.0M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in October 2022.
Who are Isosceles Pharmaceuticals's investors?
Isosceles Pharmaceuticals's investors include Equifund.
Where is Isosceles Pharmaceuticals headquartered?
Isosceles Pharmaceuticals is headquartered in Wilmington, United States.
What does Isosceles Pharmaceuticals do?
Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.
What stage is Isosceles Pharmaceuticals at?
Isosceles Pharmaceuticals is at the Equity Crowdfunding stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Isosceles Pharmaceuticals — Funding & Investors." VCBacked, October 3, 2022, https://www.vcbacked.co/company/isosceles-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2022). Isosceles Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/isosceles-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Isosceles Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/isosceles-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K